Tubular/Cribriform Carcinoma



Tubular/Cribriform Carcinoma












Tubular carcinoma is a special histologic type of breast cancer associated with a low metastatic potential. Favorable prognosis is restricted to tumors that consist entirely of tubular elements image.






Cribriform carcinoma is often seen in conjunction with tubular carcinoma, and mixed tubular and cribriform growth patterns are frequently encountered. These carcinomas have an excellent prognosis.


TERMINOLOGY


Abbreviations



  • Tubular carcinoma (TC)


  • Cribriform carcinoma (CC)


Definitions



  • TC and CC are very well-differentiated carcinomas that have low metastatic potential and excellent prognosis


ETIOLOGY/PATHOGENESIS


Molecular Pathology



  • TC is frequently associated with



    • Low-grade DCIS (LGDCIS) (˜ 90% of cases)


    • Columnar cell change (95-100% of cases)


    • Lobular neoplasia (ALH and LCIS; 15-55% of cases) (“Rosen triad”)


    • In the majority of cases, columnar cell change is associated with flat epithelial atypia (FEA)


  • Molecular analysis reveals similar genetic alterations shared by FEA, LGDCIS, and TC



    • Frequent loss of 16q and gain of 1q



      • May represent biological progression along low-grade breast neoplasia pathway


      • Supports a possible precursor role for LGDCIS and FEA progressing to TC


    • Associated lobular neoplasia has not been shown to share the same genetic changes


  • Gene expression profiling shows that TC and CC are within the luminal A group of cancers


CLINICAL ISSUES


Epidemiology



  • Incidence



    • 1-4% of breast cancers in unscreened populations


    • 10-30% of screen-detected breast cancers


  • Age



    • Most common in women in their 50s to 60s undergoing mammographic screening


Presentation



  • 60-70% present as nonpalpable, mammographically detected irregular masses



    • Most patients have small carcinomas (< 2 cm) and negative lymph nodes at presentation


    • More likely to be detected by mammography than other cancers


  • Multicentric involvement of ipsilateral breast is present in 20-50% of patients


Prognosis



  • TC and CC have excellent prognosis compared with other types of breast cancer


  • Favorable prognosis restricted to TC and CC that conform to strict histologic criteria



    • > 90% of the carcinoma must consist of well-formed tubules &/or cribriform areas


  • Few patients (10-20%) have positive nodes; may not impact overall survival



    • Multifocal and larger carcinomas are more likely to be associated with lymph node metastases


    • In general, only 1-3 nodes are involved


IMAGE FINDINGS


Mammographic Findings



  • Small irregular mass


  • Associated amorphous or pleomorphic microcalcifications in up to 50%, often due to secretory material in tubules



MACROSCOPIC FEATURES


General Features



  • Irregular gray-white mass with retraction of surrounding tissue


Size



  • Majority of TC are ≤ 1 cm, especially when mammographically detected


MICROSCOPIC PATHOLOGY


Tubular Carcinoma



  • Haphazard infiltrative proliferation of well-formed glands



    • Single layer of epithelial cells



      • No surrounding myoepithelial cell layer


      • Stromal myofibroblasts apposed to base of glands can mimic myoepithelial cells on H&E and IHC


    • Cells are low grade



      • Nuclei slightly larger than normal luminal nuclei (score 1 or 2 for grading)


      • Nucleoli are small and uniform


      • Chromatin is uniform


      • Apical cytoplasmic snouts are common


      • Mitoses are rare


    • Tubules have open lumens and angulated contours with tapering ends



      • > 90% of tumor should demonstrate characteristic tubular morphology to be considered TC


      • Calcifications may be associated with secretory material in lumens


    • Desmoplastic stromal reaction should be present and may be prominent



      • Prominent stromal elastosis may be present in some cases


    • Tubules often invade around normal ducts and lobules


    • Lymph-vascular invasion is highly unusual


    • TC frequently associated with low-grade DCIS



      • DCIS typically has cribriform and micropapillary patterns


    • TC also frequently associated with columnar cell changes, FEA, ALH, and LCIS


Cribriform Carcinoma



  • Haphazard infiltration of stroma by cribriform nests imparting a fenestrated appearance



    • Resembles cribriform DCIS



      • Unlike DCIS, nests of tumor cells may be found surrounding normal structures


      • CC lacks myoepithelial cells


    • CC usually associated with desmoplastic stromal reaction


    • Cytologic features are similar to those of TC


ANCILLARY TESTS


Immunohistochemistry



  • Hormone receptors



    • Both TC and CC typically show high levels of ER (> 95%) and PR (> 75%) expression


    • If result is negative, test should be repeated to confirm


  • HER2



    • TC and CC rarely (if ever) show HER2 overexpression or gene amplification


  • Ki-67



    • Usually have a low proliferative index (usually fewer than 10% positive cells)


  • Myoepithelial markers



    • IHC is often necessary to distinguish TC from other benign adenosis lesions



      • TC and CC lack myoepithelial cells


      • Benign lesions have a myoepithelial layer, which is often prominent


      • Microglandular adenosis lacks myoepithelial cells but will be negative for ER and PR


    • Muscle markers are positive in myoepithelial cells as well as in stromal myofibroblasts



      • Stromal cells apposed to base of tumor cells should not be mistaken for myoepithelial cells



DIFFERENTIAL DIAGNOSIS


Sclerosing Adenosis



  • Circumscribed or nodular appearance



    • Maintains lobulocentric architecture


    • In unusual cases, portions of lesion can have infiltrative pattern into adjacent breast tissue


  • Ductal structures have compressed or obliterated lumens



    • Ductal structures are usually back-to-back and typically have parallel or whirling patterns


  • Myoepithelial cells are present and often prominent



    • IHC can be helpful to document myoepithelial cells


  • Associated FEA, ADH, or DCIS are less common than in TC or CC


Microglandular Adenosis

Jul 6, 2016 | Posted by in PATHOLOGY & LABORATORY MEDICINE | Comments Off on Tubular/Cribriform Carcinoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access